INSM INSMED Inc

NEUTRAL Impact: 3/10 Insider Cluster (2 insiders)
Horizon weeks Filed May 4, 2026 Processed 1mo ago
Insider cluster: 2 insiders, $1.3M total
Latest settled — T+20d
INSM ▼ -24.27% at T+20d
NEUTRAL call ✗ call lost -24.27% · α vs SPY -29.91% · entry $140.01 → $106.03
Next anchor: T+60d in 6w
Currently $97.85 · -30.11% from $140.01 entry
Entry anchored
May 1, 03:59 PM ET
via Databento tick
T+1d
-0.41%
call -0.41% · α -1.20%
$139.44
settled 6w ago
T+5d
-25.80%
call -25.80% · α -28.73%
$103.89
settled 5w ago
T+20d
-24.27%
call -24.27% · α -29.91%
$106.03
settled 12d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

Insmed's CEO and CMO sold a combined $1.27M in stock within a week of a strong Q1 2026 earnings beat (revenue up 230% YoY, EPS beat). The CMO's sale ($1.22M) is a cash-out following option exercises; the CEO's sale ($58K) is routine. At 0.005% of market cap, the total is trivial and likely liquidity-driven, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
2

Actionable Insight

The insider sales are too small to be informative. Focus on the strong Q1 earnings and BRINSUPRI launch trajectory as the primary catalysts. Monitor for any larger insider sales in the coming weeks that could signal a change in sentiment.

Key Facts

  • CEO William Lewis sold 433 shares for ~$58K on May 4, 2026.
  • CMO Martina Flammer sold 12,119 shares for ~$1.22M on May 11, 2026, following option exercises.
  • Total cluster value of $1.27M represents ~0.005% of INSM's $25.1B market cap.
  • Q1 2026 revenue of $306M (up 230% YoY) and EPS beat consensus; BRINSUPRI guidance reiterated at ≥$1B.
  • All cross-filing context pairs are AMPLIFIERS, but the dollar amount is too small to warrant escalation.

Financial Impact

Total insider sales of $1.27M, negligible relative to $25.1B market cap.

insider holdings

Risk Factors

  • Insider sales could accelerate if the stock continues to rally post-earnings.
  • Any negative news on BRINSUPRI reimbursement or competition could reverse recent gains.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (28 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INSM-1778705432876
19 reports for INSM
Performance horizon
100% Hit rate 8 of 8 directional calls best @ T+20▲ +12.95%Apr 7, 2026
Filters
Rows
Reports for INSM — sortable, filterable
Type Now
Jun 5, 2026
7d ago
Insider Cluster
NEUTRAL ★ 2/10
$94.15 awaiting T+5awaiting T+5$97.85 (+3.93%)
Jun 5, 2026
7d ago
Insider Cluster
NEUTRAL ★ 2/10
$103.78 awaiting T+5awaiting T+5$97.85 (−5.71%)
May 16, 2026
27d ago
ANALYST-UPGRADE
BULLISH ★ 5/10
$153.32 $163.03▲ +6.33%▲ +2.03%$97.85 (−36.18%)
May 15, 2026
28d ago
S-3ASR
NEUTRAL ★ 3/10
$107.15 $108.87▲ +1.61%▼ −0.01%$97.85 (−8.68%)
May 15, 2026
28d ago
Insider Cluster
NEUTRAL ★ 3/10
$107.15 $108.87▲ +1.61%▼ −0.01%$97.85 (−8.68%)
May 13, 2026
4w ago
144
NEUTRAL ★ 2/10
$115.62 $109.53▼ −5.27%▼ −4.55%$97.85 (−15.37%)
May 7, 2026
5w ago
8-K
BULLISH ★ 6/10
$105.00 $117.99▲ +12.37%▲ +10.87%$97.85 (−6.81%)
May 4, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$140.01 $103.89▼ −25.80%▼ −28.73%$97.85 (−30.11%)
Apr 16, 2026
8w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$142.79 $143.83▲ +0.73%▼ −0.26%$97.85 (−31.47%)
Apr 16, 2026
8w ago
ANALYST-UPGRADE
MIXED ★ 6/10
$142.79 $143.83▲ +0.73%▼ −0.26%$97.85 (−31.47%)
Showing 10 of 19

US Market Status

Market Closed — Opens Mon (49h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access